Delivery Order SPE2DR25D1047-SPE2DR26F24D8
Award Date 12/29/25
Potential Completion Date 1/21/26
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg tablets (7-count units) under a firm fixed-price contract valued at $17,119.68. The order, issued on December 30, 2025, is scheduled for completion by January 22, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's capability to meet federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,559.84 to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg tablets (7-count units) under a firm fixed price contract. The delivery order was competitively awarded without set-aside designation, with performance to be completed by January 22, 2026. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply contract, which supports federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,122.82 to AmerisourceBergen Drug Corp for the supply of Ibrance 75 mg capsules (21-count units). This firm fixed-price delivery order, issued on November 18, 2025, with completion targeted for December 10, 2025, represents a non-competitive set-aside award supporting federal pharmaceutical procurement needs. The product will be supplied from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,561.41 for Ibrance 75 mg tablets (7-count units) on December 11, 2025, with completion scheduled for January 5, 2026. This firm fixed-price delivery order represents a non-compete award to the pharmaceutical distributor for supply to federal medical procurement needs. The place of performance is listed as AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $8,122.48 to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg tablets (quantity 7s) on August 26, 2025, with an ultimate completion date of September 17, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,122.48 on August 12, 2025, for the supply of Ibrance 100 mg tablets (7-unit package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,236.16 to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg tablets (7-count units) on August 25, 2025, with completion scheduled for September 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Ibrance 100 mg tablets in a seven-count configuration, with a ceiling value of $8,559.84 and firm fixed pricing. This is a non-set-aside competitive award with an ultimate completion date of December 19, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Ibrance 75 mg tablets (quantity 7) with a ceiling value of $8,561.41. This firm fixed-price delivery order, with an ultimate completion date of January 22, 2026, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ibrance 100 mg tablets (quantity 7s) with a ceiling value of $8,122.48. This firm fixed-price delivery order, with a completion date of September 30, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...